BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2024 7:20:40 AM | Browse: 346 | Download: 1144
Publication Name World Journal of Nephrology
Manuscript ID 95410
Country India
ISSN 2220-6124 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research & Experimental
Manuscript Type Editorial
Article Title Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism
Manuscript Source Invited Manuscript
All Author List Pitchai Balakumar
ORCID
Author(s) ORCID Number
Pitchai Balakumar http://orcid.org/0000-0003-1940-1296
Funding Agency and Grant Number
Corresponding Author Pitchai Balakumar, PhD, Director, Director, Professor, The Office of Research and Development, Periyar Maniammai Institute of Science & Technology (Deemed to be University), Vallam, Thanjavur 613403, Tamil Nadu, India. pbalakumar2022@gmail.com
Key Words Diabetes mellitus; Epithelial-to-mesenchymal transition; E-cadherin; N-cadherin; Renal fibrosis; Diabetic nephropathy
Core Tip Measures to maintain epithelial integrity and prevent epithelial-to-mesenchymal transition (EMT) are being investigated as prospective therapeutic options for diabetic nephropathy. Understanding the role of EMT in diabetic nephropathy lays the door for potential therapeutic approaches. The use of TGF-β inhibitors, renal anti-inflammatory agents, antifibrotics, and antioxidants to target EMT-related pathways and renal fibrosis may have the potential to reduce the evolution of diabetic nephropathy and to prevent kidney damage.
Publish Date 2024-06-25 07:20
Citation

Balakumar P. Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism. World J Nephrol 2024; 13(2): 95410

URL https://www.wjgnet.com/2220-6124/full/v13/i2/95410.htm
DOI https://dx.doi.org/10.5527/wjn.v13.i2.95410
Full Article (PDF) WJN-13-95410-with-cover.pdf